These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7104230)

  • 1. Stroma free human platelet lysates potentiate the in vivo thrombogenicity of factor Xa by the provision of coagulant-active phospholipid.
    Giles AR; Nesheim ME; Hoogendoorn H; Tracy PB; Mann KG
    Br J Haematol; 1982 Jul; 51(3):457-68. PubMed ID: 7104230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbits.
    Giles AR; Nesheim ME; Hoogendoorn H; Tracy PB; Mann KG
    Blood; 1982 Feb; 59(2):401-7. PubMed ID: 7034817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell generation of thrombin via functional prothrombinase assembly.
    VanDeWater L; Tracy PB; Aronson D; Mann KG; Dvorak HF
    Cancer Res; 1985 Nov; 45(11 Pt 1):5521-5. PubMed ID: 4053025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of prothrombinase complex by plasma proteinase inhibitors.
    Ellis V; Scully MF; Kakkar VV
    Biochemistry; 1984 Nov; 23(24):5882-7. PubMed ID: 6335402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of factor Xa inhibitors on the platelet-derived microparticles procoagulant activity in vitro and in vivo in rats.
    Hérault JP; Perrin B; Jongbloet C; Pflieger AM; Bernat A; Herbert JM
    Thromb Haemost; 2000 Oct; 84(4):668-74. PubMed ID: 11057868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a congenital dysthrombin, thrombin Quick.
    Henriksen RA; Owen WG; Nesheim ME; Mann KG
    J Clin Invest; 1980 Nov; 66(5):934-40. PubMed ID: 6776145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of inhibition of platelet coagulant activity.
    Ellis V; Scully MF; Kakkar VV
    Adv Exp Med Biol; 1985; 192():373-87. PubMed ID: 2422887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the platelet factor V content to platelet factor 3 activity.
    van Zutphen H; Bevers EM; Hemker HC; Zwaal RF
    Br J Haematol; 1980 May; 45(1):121-31. PubMed ID: 7189664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet prothrombinase in health and disease.
    Crook M
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):167-74. PubMed ID: 2130928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex.
    Yegneswaran S; Banerjee Y; Fernández JA; Deguchi H; Griffin JH
    PLoS One; 2015; 10(8):e0135025. PubMed ID: 26263376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet procoagulant properties studied with snake venom prothrombin activators.
    Speijer H; Govers-Riemslag JW; Zwaal RF; Rosing J
    Thromb Haemost; 1987 Jun; 57(3):349-55. PubMed ID: 3310319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of factor Va by atherosclerotic rabbit aorta mediates factor Xa-catalyzed prothrombin activation.
    Rodgers GM; Kane WH; Pitas RE
    J Clin Invest; 1988 Jun; 81(6):1911-9. PubMed ID: 3164315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and study of an acquired inhibitor of human coagulation factor V.
    Nesheim ME; Nichols WL; Cole TL; Houston JG; Schenk RB; Mann KG; Bowie EJ
    J Clin Invest; 1986 Feb; 77(2):405-15. PubMed ID: 3944265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of coagulation factor V by a platelet protease.
    Kane WH; Mruk JS; Majerus PW
    J Clin Invest; 1982 Nov; 70(5):1092-100. PubMed ID: 6752201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation/inactivation of human factor V by plasmin.
    Lee CD; Mann KG
    Blood; 1989 Jan; 73(1):185-90. PubMed ID: 2521293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of procoagulant binding sites on the platelet surface.
    Bevers EM; Rosing J; Zwaal RF
    Adv Exp Med Biol; 1985; 192():359-71. PubMed ID: 3914834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.